Valuation (43%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 63.61 | 31.36 |
| PEG Ratio (TTM) | 1.04 | -1.09 |
| P/S Ratio (TTM) | 2.51 | 4.72 |
| P/B Ratio (TTM) | 4.38 | 6.08 |
| P/FCF Ratio (TTM) | 17.94 | 34.24 |
| Price to 5YR AVG Earnings Ratio | -8,863.01 | 46.89 |
| Price to 5YR AVG FCF Ratio | 126.74 | 52.49 |
Profitability (18%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.11% | 8.78% |
| ROE (TTM) | 7.21% | 21.59% |
| Net Profit Margin (TTM) | 3.95% | 11.27% |
| ROIC 5YR AVG | 0.16% | 20.62% |
Growth (85%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 190.07% | 95.19% | 281.45% |
| Revenue | 4.56% | 10.75% | 59.70% |
| Net Income | 196.06% | 88.35% | 281.36% |
| Cash Flow | 51.88% | -117.40% | 95.39% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.08 | 1.73 |
| Quick Ratio (TTM) | 0.83 | 1.16 |
| D/E Ratio (TTM) | N/A | 0.62 |
| Interest Coverage (TTM) | 268.16 | 17.55 |
| Piotroski F-Score | 7 | 7 |
| Altman Z-Score | 3.61 | 5.35 |
| LTL to 5YR AVG FCF | 3.35 | 6.03 |
| Shares Outstanding Growth 5YR AVG | 1.83% | 0.62% |